Van Eck Global - Since 1955

Van Eck VIP Emerging Markets Fund

  • Van Eck VIP Emerging Markets Fund

  • Ticker:- WWEM;false;;
  •  

    The Van Eck VIP Emerging Markets Fund seeks long-term capital appreciation by investing in equity securities in emerging markets around the world. The Fund is a global emerging markets equity portfolio focused on companies with growth potential at a reasonable price (“GARP”). Our bottom-up investment process is driven by fundamental research into the sustainability of a company’s growth drivers, and is oriented toward strong secular stories, many of which reflect domestic demand themes and are often found in smaller-capitalization stocks.

  • Fund Details

     

    as of 06/30/14
    Net Assets $171.5M P/E (LTM) / P/E (Forward) 14.2 / 13.0
    Number of Holdings 83 P/B (LTM) 2.4
    Turnover Rate (2013) 83% Average Weighted Market Cap $6.0B
  • Fund Summary

     

    The Fund seeks long-term capital appreciation by investing primarily in equity securities in emerging markets around the world. The Fund's benchmark is the Morgan Stanley Capital International Emerging Markets Index.

  • Country Weightings (%)

     

    as of 06/30/14
    China 24.4
    India 14.0
    Brazil 8.7
    South Korea 6.9
    Taiwan 6.2
    Russia 6.1
    Nigeria 2.7
    Saudi Arabia 2.5
    Singapore 2.4
    Switzerland 2.4
    Virgin Islands 1.9
    Turkey 1.8
    Other 15.0
    Cash 5.0

  • Sector Weightings (%)

     

    as of 06/30/14
    Financials 24.3
    Consumer Discretionary 19.3
    Information Technology 16.7
    Industrials 9.3
    Energy 7.2
    Consumer Staples 7.0
    Health Care 7.0
    Materials 4.2
    [Cash] 5.0
    Total 100.0
  • Top Ten Holdings (%)

     

    as of 06/30/14
    Ezion Holdings Limited Ltd Pfd 2.4
    Glencore plc 2.4
    Estacio Participacoes S.A. 2.3
    BB Seguridade Participacoes S.A. 2.2
    Tencent Holdings Ltd 2.2
    Tech Mahindra Limited 2.2
    Taiwan Semiconductor Manufacturing Co. Ltd. 2.1
    Samsung Electronics Co Ltd Pfd 2.0
    Glenmark Pharmaceuticals Limited 2.0
    Magnit JSC 2.0

    View All Holdings

    These are not recommendations to buy or sell any security. Sectors and holdings may vary.
  • Market Capitalization (Cap) Breakdown (%)

     

    as of 06/30/14
    Large (≥ $10 billion) 34.3%
    Mid (< $10 billion ≥ $2 billion) 45.9%
    Small (< $2 billion) 19.8%
    Average Weighted Market Cap $6.0B
  • Important Disclosure 

    You can lose money by investing in the Fund. Any investment in the Fund should be considered part of an overall investment program, not a complete program. The Fund is subject to the risks associated with its investments in emerging market securities, which tend to be more volatile and less liquid than securities traded in developed countries. The Fund’s investments in foreign securities involve risks related to adverse political and economic developments unique to a country or a region, currency fluctuations or controls, and the possibility of arbitrary action by foreign governments, including the takeover of property without adequate compensation or imposition of prohibitive taxation. The Fund is subject to risks associated with investments in debt securities, derivatives, commodity-linked instruments, illiquid securities, asset-backed securities, CMOs and small or mid-cap companies. The Fund is also subject to inflation risk, short-sales risk, market risk, non-diversification risk and leverage risk.

    The Morgan Stanley Capital International (MSCI) Emerging Markets Index, calculated with dividends reinvested, captures 60% of the publicly traded equities in each industry for approximately 21 emerging markets.

    Indices are unmanaged and are not securities in which investments can be made.

    The Fund is only available as an option under various insurance contracts issued by life insurance and annuity companies. These contracts offer life and tax benefits to the beneficial owners of the Fund. The insurance or annuity company charges, fees and expenses for these benefits are not included in Fund performance. A review of the particular life and/or annuity contract will provide you with much greater detail regarding these costs and benefits.

    The Fund is not available directly to the general public. For more complete information on variable life/annuity products, including all charges and expenses, please obtain a prospectus from a licensed insurance agent/registered representative. The prospectus includes information about the investment objective, risks and charges and expenses. Please read the prospectus carefully before investing. 

    Not FDIC Insured — No Bank Guarantee — May Lose Value